Skip to content
AnalystLens
Back to ROIVIncome Statement

Roivant Sciences EPS (Diluted) 2022-2027 | ROIV

Annual FY2022–FY2026 · quarterly through Q1 FY2027

Latest annual · FY2026

−$0.54

−125.0%YoY vs FY2025Source: 10-KFY2026

From −$1.26 in FY2022 to −$0.54 in FY2026.

By quarter▲▼ vs a year before
Fiscal yearQ1Q2Q3Q4
FY27−$0.26+21.2%Not reportedNot reportedNot reported
FY26−$0.33−375.0%−$0.17+45.2%−$0.38−265.2%Not reported
FY25$0.12+131.6%−$0.31+22.5%$0.23−96.2%Not reported
FY24−$0.38+20.8%−$0.40+4.8%$6.03+1330.6%Not reported
FY23−$0.48−269.2%−$0.42−31.2%−$0.49−19.5%Not reported

Shaded by size: darkest is the largest quarter shown; ringed is the latest reported; a dash marks a quarter with no separate figure. Each quarter sits by its period-end date.

Key Statistics

Trend DirectionDeclining
CAGR

N/A

FY2022
−$1.26
FY2026
−$0.54

4 years selected · on the chart

EPS (Diluted) History

Year-over-year comparison from 10-K annual reports

  1. −$0.54
YoY changeLargest recent move−12.7%in FY23Latest −125.0%

1 older move runs past ±150% (largest +468.3%); point at, tap or drag across the bars to read one.

EPS (Diluted), period by period

PeriodValueChangeSource
FY2026−$0.54−125.0%10-K
FY2025−$0.24−104.6%10-K
FY2024$5.23+468.3%10-K
FY2023−$1.42−12.7%10-K
FY2022−$1.26—10-K

What is eps (diluted)?

Diluted earnings per share (EPS) can be defined as net income divided by the total number of shares outstanding including all dilutive securities such as stock options, warrants, and convertible bonds.

What is Roivant Sciences's current eps (diluted)?

Roivant Sciences (ROIV) annual eps (diluted) for 2026 was $-0.54, a 125.00% decline from 2025. Roivant Sciences eps (diluted) for the quarter ending June 30, 2026 was $-0.26.

What was Roivant Sciences's eps (diluted) in 2025?

Roivant Sciences annual eps (diluted) for 2025 was $-0.24, a 104.59% decline from 2024.

What was Roivant Sciences's eps (diluted) in 2024?

Roivant Sciences annual eps (diluted) for 2024 was $5.23, a 468.31% increase from 2023.

Company
Roivant Sciences
Ticker
ROIV
Sector
Healthcare
Industry
Pharmaceutical Preparations